...
首页> 外文期刊>Journal of biomedical materials research, Part A >Poly(DL-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices.
【24h】

Poly(DL-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices.

机译:聚(DL-乳酸)膜表面改性用肝素改善血液接触性能吸收器件的血液相位性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This work describes a simple method to immobilize heparin by covalent bonding to the surface of poly(lactic acid) film with the aim of showing improved hemocompatibility. Carboxyl groups present in heparin molecules were activated by reaction with N-hydroxy-succinimide and allowed to react with free amino groups created at the surface of poly(DL-lactic acid) films by controlled aminolysis. Contact angle measurements and XPS analysis confirmed the binding. Quantification was determined by radioactivity using heparin labeled with tritium. The surface exhibited anti factor Xa activity, thus confirming the presence of bounded heparin that kept some biological activity. Finally platelets adhesion showed less platelet adhesion on heparin modified films as well as preserved morphology.
机译:这项工作描述了一种通过与聚(乳酸)膜的表面的共价键合来固定肝素的简单方法,目的是显示出改善的血液相位性。 肝素分子中存在的羧基通过与N-羟基 - 琥珀酰亚胺反应而活化,并通过受控氨基溶液与在聚(D1-乳酸)薄膜表面上产生的游离氨基反应。 接触角测量和XPS分析证实了绑定。 使用用氚标记的肝素用肝素进行放射性测定量化。 表面表现出抗因子Xa活性,从而确认存在保持一些生物活性的有界肝素的存在。 最后血小板粘附在肝素改性薄膜上显示较少的血小板粘附以及保存的形态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号